Creation and internal assessment of a nomogram tailored for lymphoma to forecast venous thromboembolism risk: analysis of a retrospective cohort comprising 790 patients - Top-Institutions - MDSpire

Creation and internal assessment of a nomogram tailored for lymphoma to forecast venous thromboembolism risk: analysis of a retrospective cohort comprising 790 patients

  • By

  • Lili Pan

  • Wenzheng Lin

  • Yanyan Qiu

  • Jinhua Chen

  • Nainong Li

  • Tingbo Liu

  • November 5, 2025

  • 0 min

Share

Top Institutions in Hematology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Hematology
    • Oncology
    • Thrombosis Research

  • #2

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Hematology
    • Oncology
    • Clinical Epidemiology

  • #3

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Hematology
    • Oncology
    • Thrombosis and Hemostasis

  • #4

    Fujian Medical University Union Hospital
    Fujian Medical University Union Hospital

    Fuzhou, Fujian Province, China

    Key Differentiators

    • Hematology
    • Oncology

  • #5

    University of Toronto, Princess Margaret Cancer Centre
    University of Toronto, Princess Margaret Cancer Centre

    Toronto, ON

    Key Differentiators

    • Hematology
    • Oncology
    • Clinical Research

Original Source(s)

Creation and internal assessment of a nomogram tailored for lymphoma to forecast venous thromboembolism risk: analysis of a retrospective cohort comprising 790 patients

  • by Lili Pan, Wenzheng Lin, Yanyan Qiu, Jinhua Chen, Nainong Li, Tingbo Liu

  • November 5, 2025

Related Content

Myelodysplastic syndromes complicated by atypical Sweet syndrome: a brief research report

Long-term low-dose sirolimus therapy and successful discontinuation in an adult with kaposiform lymphangiomatosis and disseminated intravascular coagulation: a case report

Advanced strategies to enhance the safety, persistence, and efficacy of CAR-T cells in solid tumors